Eikon Therapeutics Stock Price, News & Analysis
Company Description
Eikon Therapeutics (NASDAQ: EIKN) is a publicly traded biotechnology company in the Biological Products, (no Diagnostic Substances) sector. The company has a market capitalization of $534.4M, ranking #3,405 among all listed U.S. companies by market cap.
EIKN stock has declined 34.0% over the past year. Shares last traded at $9.90.
This page provides a comprehensive overview of EIKN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Eikon Therapeutics (EIKN) stock last traded at $9.90. Over the past 12 months, the stock has lost 34.0%. At a market capitalization of $534.4M, EIKN is classified as a small-cap stock with approximately 54.0M shares outstanding.
Latest News
Eikon Therapeutics has 2 recent news articles, with the latest published 4 days ago. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include earnings, IPO, offering. View all EIKN news →
SEC Filings
Eikon Therapeutics has filed 5 recent SEC filings, including 3 Form 4, 1 Form 8-K, 1 Form 10-K. The most recent filing was submitted on March 30, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all EIKN SEC filings →
Insider Radar
Insider buying activity at Eikon Therapeutics over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
TeLuRide-005 data readout
EIK1003/EIK1004 cohort start
Cash runway into 2H 2027
Eikon Therapeutics has 3 upcoming scheduled events. The next event, "TeLuRide-005 data readout", is scheduled for July 1, 2026 (in 88 days). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the EIKN stock price.
Short Interest History
Short interest in Eikon Therapeutics (EIKN) currently stands at 2.2 million shares, up 36.0% from the previous reporting period, representing 12.3% of the float. Over the past 12 months, short interest has increased by 149.5%. This moderate level of short interest indicates notable bearish positioning. The 6.6 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Eikon Therapeutics (EIKN) currently stands at 6.6 days, up 461.9% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 461.9% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.2 to 6.6 days.
EIKN Company Profile & Sector Positioning
Eikon Therapeutics (EIKN) operates in the Biotechnology industry within the broader Biological Products, (no Diagnostic Substances) sector and is listed on the NASDAQ.